Literature DB >> 14984280

Cost data assessment in multinational economic evaluations: some theory and review of published studies.

Richard G Halliday1, Josep Darba.   

Abstract

This article reviews the concept of costing, and how cost data have been considered and reported in recent multinational economic evaluations. It appears that current practice frequently does not comply with microeconomic foundations and standards for good practice. A number of studies fail to indicate the year of costing data, the explicit source(s) of such data, the ranges of variables chosen for sensitivity analysis, and the rates used for the translation of currencies and for inflation or deflation. Consequently, caution should be exercised if using such papers as sources of cost data. It is recommended that differences between countries, both in terms of quantities of resources used and of unit prices, should be clearly stated in the presentation of results, as well as the method of calculating overall findings from the various country-specific results.

Mesh:

Year:  2003        PMID: 14984280

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  6 in total

1.  Providing systematic guidance in pharmacoeconomic guidelines for analysing costs.

Authors:  Philip Jacobs; Arto Ohinmaa; Bruce Brady
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  Estimating drug costs in economic evaluations in Ireland and the UK: an analysis of practice and research recommendations.

Authors:  Dyfrig A Hughes; Lesley Tilson; Michael Drummond
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  In Brief: cost-effectiveness analyses in orthopaedics.

Authors:  Patrick Vavken; Thomas Bianchi
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

4.  Basing care reforms on evidence: the Kenya health sector costing model.

Authors:  Steffen Flessa; Michael Moeller; Tim Ensor; Klaus Hornetz
Journal:  BMC Health Serv Res       Date:  2011-05-27       Impact factor: 2.655

5.  HERALD (health economics using routine anonymised linked data).

Authors:  Muhammad J Husain; Sinead Brophy; Steven Macey; Leila M Pinder; Mark D Atkinson; Roxanne Cooksey; Ceri J Phillips; Stefan Siebert
Journal:  BMC Med Inform Decis Mak       Date:  2012-03-29       Impact factor: 2.796

Review 6.  The economics of vision impairment and its leading causes: A systematic review.

Authors:  Ana Patricia Marques; Jacqueline Ramke; John Cairns; Thomas Butt; Justine H Zhang; Iain Jones; Marty Jovic; Allyala Nandakumar; Hannah Faal; Hugh Taylor; Andrew Bastawrous; Tasanee Braithwaite; Serge Resnikoff; Peng T Khaw; Rupert Bourne; Iris Gordon; Kevin Frick; Matthew J Burton
Journal:  EClinicalMedicine       Date:  2022-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.